Trial Evaluating Nutritional Fiber in Digestive Symptoms of Endometriosis

Summary

This study is a double-blind, randomized, placebo-controlled study that evaluates the safety and tolerability of a fiber-based dietary supplement and the mechanistic and structure-function effects of that supplement on the gut and vaginal microbiome, gastrointestinal well-being, and quality-of-life parameters in 140 women with endometriosis and co-existing gastrointestinal symptoms over 12 weeks. The primary objective is to evaluate the safety and tolerability of the supplement, measured by the incidence and severity of gastrointestinal adverse events (AEs) and discontinuations.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Endometriosis
• Microbiome Dysbiosis
• Gastrointestinal Symptoms

Eligibility basics and study details

Study type

Interventional

Phase

Not applicable

Ages

18 to 45 years

Sex

Female

Healthy volunteers

Accepted

Sponsor

LOAM Science

Last updated on ClinicalTrials.gov

October 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites